Showing 1 to 2 of 2 results


Biocon's Biosimilar Strategy Disrupts Global Healthcare
Kiran Mazumdar-Shaw, thwarted in her brewing ambitions, founded Biocon, a $1.9 billion biopharmaceutical company producing cheaper biosimilar drugs, impacting global healthcare access and resulting in a $3.2 billion personal fortune.
Biocon's Biosimilar Strategy Disrupts Global Healthcare
Kiran Mazumdar-Shaw, thwarted in her brewing ambitions, founded Biocon, a $1.9 billion biopharmaceutical company producing cheaper biosimilar drugs, impacting global healthcare access and resulting in a $3.2 billion personal fortune.
Progress
44% Bias Score

China's Progress Across Multiple Sectors Highlighted at CPPCC Press Interview
At a press interview on March 4, 2025, CPPCC members highlighted China's advancements in the Belt and Road Initiative, robotics, the silver economy, agricultural technology, biopharmaceuticals, and urban renewal, showcasing the nation's progress across various sectors.

China's Progress Across Multiple Sectors Highlighted at CPPCC Press Interview
At a press interview on March 4, 2025, CPPCC members highlighted China's advancements in the Belt and Road Initiative, robotics, the silver economy, agricultural technology, biopharmaceuticals, and urban renewal, showcasing the nation's progress across various sectors.
Progress
48% Bias Score
Showing 1 to 2 of 2 results